ibrutinib (imbruvica) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$74.7208 - $74.8374

VA Big4

$103.4157 - $313.0564

VA FSS

$132.3268 - $405.9757

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ibrutinib 140 mg (CAPSULE) $74.7208 AUS PBS generic
  • Imbruvica (120)
    		•  Janssen-Cilag Pty Ltd
    ibrutinib 140 mg (CAPSULE) $74.8374 AUS PBS generic
  • Imbruvica (90)
    		•  Janssen-Cilag Pty Ltd
    ibrutinib 140 mg (CAPSULE) $103.4157 VA Big4
  • Imbruvica (90)
    		•  Pharmacyclics, LLC
    ibrutinib 140 mg (CAPSULE) $104.6367 VA Big4
  • Imbruvica (120)
    		•  Pharmacyclics, LLC
    ibrutinib 140 mg (CAPSULE) $132.3268 VA FSS
  • Imbruvica (120)
    		•  Pharmacyclics, LLC
    ibrutinib 140 mg (CAPSULE) $132.3269 VA FSS
  • Imbruvica (90)
    		•  Pharmacyclics, LLC
    ibrutinib 140 mg (TABLET) $309.4296 VA Big4
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 140 mg (TABLET) $405.9757 VA FSS
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 280 mg (TABLET) $310.4857 VA Big4
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 280 mg (TABLET) $405.9757 VA FSS
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 420 mg (TABLET) $310.4839 VA Big4
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 420 mg (TABLET) $405.9757 VA FSS
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 560 mg (TABLET) $311.2386 VA Big4
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 560 mg (TABLET) $405.9757 VA FSS
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 70 mg (CAPSULE) $313.0564 VA Big4
  • Imbruvica (28)
    		•  Pharmacyclics, LLC
    ibrutinib 70 mg (CAPSULE) $405.9757 VA FSS
  • Imbruvica (28)
    		•  Pharmacyclics, LLC

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue